Vancomycin-Loaded Microneedle Arrays against Methicillin-Resistant Staphylococcus Aureus Skin Infections

Research output: Contribution to journalJournal articleResearchpeer-review


  • Jill Ziesmer
  • Poojabahen Tajpara
  • Nele-Johanna Hempel
  • Marcus Ehrstrom
  • Keira Melican
  • Eidsmo, Liv
  • Georgios A. Sotiriou

Skin and soft tissue infections (SSTIs) caused by methicillin-resistant Staphylococcus aureus (MRSA) are a major healthcare burden, often treated with intravenous injection of the glycopeptide antibiotic vancomycin (VAN). However, low local drug concentration in the skin limits its treatment efficiency, while systemic exposure promotes the development of resistant bacterial strains. Topical administration of VAN on skin is ineffective as its high molecular weight prohibits transdermal penetration. In order to implement a local VAN delivery, microneedle (MN) arrays with a water-insoluble support layer for the controlled administration of VAN into the skin are developed. The utilization of such a support layer results in water-insoluble needle shafts surrounded by drug-loaded water-soluble tips with high drug encapsulation. The developed MN arrays can penetrate the dermal barriers of both porcine and fresh human skin. Permeation studies on porcine skin reveal that the majority of the delivered VAN is retained within the skin. It is shown that the VAN-MN array reduces MRSA growth both in vitro and ex vivo on skin. The developed VAN-MN arrays may be extended to several drugs and may facilitate localized treatment of MRSA-caused skin infections while minimizing adverse systemic effects.

Original languageEnglish
Article number2001307
JournalAdvanced Materials Technologies
Number of pages10
Publication statusPublished - 2021

    Research areas

  • antibiotic, local delivery, microneedle patch, MRSA, PMMA

Number of downloads are based on statistics from Google Scholar and

No data available

ID: 262800304